Rheumatology Patient Registry and Biorepository

ConditionsRheumatic Diseases Adult Onset Still Disease Ankylosing Spondylitis Psoriatic Arthritis Reactive Arthritis Antiphospholipid Syndrome Systemic Lupus Erythematosus Behcet Disease Dermatomyositis Polymyositis Giant Cell Arteritis Lyme Disease Mixed Connective Tissue Disease Polymyalgia Rheumatica Rheumatoid Arthritis Sarcoidosis Systemic Sclerosis Scleroderma Sjogren's Syndrome Undifferentiated Connective Tissue Diseases

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-99

SponsorYale University

About this trial

To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients ≥18 years old with a diagnosis of a rheumatic autoimmune disease including, but not limited to: adult onset Still's disease, ankylosing spondylitis, antiphospholipid syndrome, Behcet's disease, dermatomyositis, giant cell arteritis, mixed connective tissue disease, polymyalgia rheumatica, polymyositis, psoriatic arthritis, reactive arthritis, rheumatoid arthritis, sarcoidosis, scleroderma, Sjogren's syndrome, systemic lupus erythematosus, undifferentiated connective tissue disease and vasculitis.

Receiving clinical care at Yale Rheumatology clinics

Disqualifiers

Unable to provide informed consent

No patients will be excluded based on gender or ethnicity or pregnancy status.

Women who are currently pregnant will need to wait to donate a skin biopsy until after they deliver.

Patients allergic to lidocaine or epinephrine or have a history of impaired wound healing will not be able to donate a skin biopsy.

Trial population

The biorepository will consist of both new and established patients with a rheumatic autoimmune disease diagnosis who visit a Yale Rheumatology medical facility and agree to participate in this study. The biorepository will also consist of healthy volunteers who agree to participate in this study.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

5,000 Participants

are grouped into 1 trial group

Group A: Biorepository

Trial outcomes

Primary outcomes

Correlate outcomes and biomarkers of rheumatic diseases

Evaluate clinical data and biospecimens to correlate outcomes and biomarkers of rheumatic diseases.

Time frame

10 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Yale University

Lead sponsor

Rheumatology Research Foundation

Collaborator

Source ClinicalTrials.gov

Apply now